Sumitomo Chemical to Acquire FBSciences Holdings, a Company Engaged In Business of Biostimulant

Acquisition or Partnership

Sumitomo Chemical to acquire FBSciences Holdings, Inc., a U.S. company engaged in the business of biostimulants, a group of naturally derived agricultural materials and a class of biorationals. The acquisition is Business of Biostimulantdue to be completed subject to the prescribed procedures.

FBS develops, manufactures, and markets biostimulants and biopesticides made from natural organic matter sourced and processed with its proprietary methods. With products and technologies applicable to more than 50 different crops as proven with extensive field trial data, and with over a decade of commercial success, the company has been rapidly growing its business in recent years, particularly in the U.S.

Sumitomo Chemical regards this acquisition as a step toward full-scale entry into the biostimulant field. The Sumitomo Chemical Group will strive to further expand its biorational business by combining its global footprint and resources with FBS's product portfolio and technological know-how, while also seeking to create new synergies between biorationals and conventional crop protection products.

Biorationals, which have a global market valued today at about $10 billion, about one-tenth that of agricultural chemicals, are expected to see continued demand growth as the need for crop protection products with lower environmental impact increases among growers and consumers. Biostimulants are agricultural materials derived from natural products that have the effect of drawing out the innate power of crops and soil. The biostimulant market, the largest segment of biorationals, is worth approximately $3.5 billion and is growing at double-digit rates. By inducing defenses against non-biotic stresses, biostimulants promote healthy crop growth and nutrient absorption, thereby improving crop quality and increasing yields. They also promote efficient use of chemical fertilizers and reduce their application.

Early on, Sumitomo Chemical began to focus on the potential of the biorationals business, and acquired the biorationals business of Abbott Laboratories, Inc. of the U.S. in 2000. Since then, the Company has continued to strengthen and expand the business, with its U.S. subsidiary Valent BioSciences LLC at the core of the effort. In recent years, the Sumitomo Chemical Group has accelerated strategic measures to enhance its operations in this area, including building up a production plant for active ingredients for microbial crop protection products in the U.S. in 2014, acquiring a U.S. rhizosphere microbials business in 2015, opening a biorational research center in 2018, and launching dedicated biorationals sales organizations at the Group’s major overseas locations in 2020.

Engage with ARC Advisory Group

Representative End User Clients
Representative Automation Clients
Representative Software Clients